Home・Listă Acțiuni・UroGen Pharma Ltd

UroGen Pharma Ltd

Închisă

46.3 0.78

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

45.64

Maxim

Indicatori cheie
By Trading Economics
Venit	9.2M -14M
Vânzări	21M 72M
EPS	-0.28
Marjă de profit	-19.807
Angajați	300
EBITDA	15M -3.8M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+30.42% upside

Dividende
By Acuity
Următoarele câștiguri	5 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	376M 2.3B
Deschiderea anterioară	45.52
Închiderea anterioară	46.3

UroGen Pharma Ltd Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

25 aug. 2026, 23:56 UTC

Correlated Moves

Emerson Electric Co's shares are lower in after-market hours, reflecting a decline since Tuesday's close amid broader market sentiment influencing the stock's movement.

25 aug. 2026, 23:56 UTC

Charles River Laboratories shares are higher in after-market trading, maintaining a position near the upper end of their one-month range amid lower crude oil prices.

25 aug. 2026, 23:56 UTC

Host Hotels and Resorts, Inc. shares are lower in after-market hours. No specific news was identified to explain the decline, amid falling crude oil prices.

25 aug. 2026, 23:56 UTC

Correlated Moves

KKR & Co Inc shares are lower in after-market hours, reflecting broader trends in the financial sector amid minimal change since Tuesday's close.

25 aug. 2026, 23:56 UTC

ETF Constituents

Correlated Moves

Vanguard Morningstar Mid-Cap ETF trades higher after-market, supported by contributions from HWM, PWR, VST, NET, and LHX amid a rising Russell 2000 Index.

25 aug. 2026, 23:56 UTC

Correlated Moves

M&T Bank Corp shares are lower in after-market trading, influenced by a decline in Wells Fargo and broader market sentiment affecting the banking sector.

25 aug. 2026, 23:56 UTC

Allogene Therapeutics Inc. is trading roughly flat in after-market hours, maintaining a position near the upper end of its one-month range.

25 aug. 2026, 23:56 UTC

Correlated Moves

NiSource Inc shares are trading lower in after-market hours, influenced by a decline in Sempra and broader market sentiments affecting utility stocks.

25 aug. 2026, 23:56 UTC

Toast Inc shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

25 aug. 2026, 23:56 UTC

Baker Hughes Co's shares are higher in after-market trading, with no specific news identified. Broader market trends may be influencing positive sentiment.

25 aug. 2026, 23:56 UTC

Correlated Moves

Johnson Controls International PLC shares rose in after-market trading, reflecting modest gains amid favorable investor sentiment and a correlation with nVent Electric PLC.

25 aug. 2026, 23:56 UTC

Correlated Moves

Public Service Enterprise Group Inc. sees modest gains in after-market trading, aligning with broader trends from related companies like DTE Energy Co.

25 aug. 2026, 23:56 UTC

Correlated Moves

Shares of APA Corp declined in after-market trading, continuing a trend of lower daily finishes, amid falling WTI crude oil prices.

25 aug. 2026, 23:56 UTC

Fidelity National Information Services shares are trading lower in after-market hours. The asset remains below its 20-day moving average.

25 aug. 2026, 23:56 UTC

Williams Companies Inc. shares are higher in after-market trading, reflecting a slight gain since Tuesday's close amid declining crude oil prices and lower treasury yields.

25 aug. 2026, 23:56 UTC

Diamondback Energy shares traded roughly flat in after-market hours, following four consecutive sessions of declines amid lower crude oil prices and treasury yields.

25 aug. 2026, 23:56 UTC

Correlated Moves

Fifth Third Bancorp remains roughly flat in after-market trading, despite a slight increase in the Dow Jones Index and declining crude oil prices.

25 aug. 2026, 23:56 UTC

Correlated Moves

Jones Lang LaSalle Inc shares are lower in after-market trading, reflecting a broader decline in the real estate sector alongside Marcus & Millichap Inc.

25 aug. 2026, 23:52 UTC

Mexico's Business Confidence Remains Low at 48.0 Ahead of Key Survey Amid Mixed Trade Sentiments with the U.S.

25 aug. 2026, 23:52 UTC

Brazil's Q2 2026 GDP Growth Rate Release Looms Amid Declining Consumer Confidence and Cautious Market Sentiment.

25 aug. 2026, 23:52 UTC

Brazil's Q2 2026 GDP growth release on September 1 expected to reflect strong government spending amid mixed consumer confidence and rising inflation concerns.

25 aug. 2026, 23:52 UTC

India's Current Account Balance Release on September 1, 2026 Expected to Impact Market Sentiment Amid Rising Import Costs and Geopolitical Pressures.

25 aug. 2026, 23:52 UTC

Brazil's Central Bank to Announce SELIC Rate Decision Amid Global Monetary Policy Uncertainty on August 31, 2026.

25 aug. 2026, 23:52 UTC

Social Media

Warner Bros Discovery Inc shares traded lower in after-market hours amid ongoing scrutiny in the antitrust case involving Paramount and related legal developments.

25 aug. 2026, 23:52 UTC

UniFirst Corp shares declined in after-market trading, despite a favorable macro environment with falling crude oil prices and lower Treasury yields.

25 aug. 2026, 23:51 UTC

DraftKings shares are higher in after-market trading amid favorable market conditions and a decline in crude oil prices. No specific news was identified.

25 aug. 2026, 23:51 UTC

Travel + Leisure Co shares are higher in after-market hours. No specific company news was identified, but declining crude oil prices may be influencing sentiment.

25 aug. 2026, 23:51 UTC

Correlated Moves

American Water Works shares are higher in after-market trading, supported by a decline in crude oil prices and easing inflation concerns.

25 aug. 2026, 23:51 UTC

Asia equity markets mixed as investors react to geopolitical tensions, falling crude oil prices, and await key U.S. economic data releases.

25 aug. 2026, 23:51 UTC

Mixed trading in Europe as Germany's Ifo index rises, while France's consumer confidence dips; U.S. markets gain on falling oil prices and tech stock rallies ahead of key earnings.

Comparație

Modificare preț

UroGen Pharma Ltd Așteptări

Obiectiv de preț

By TipRanks

30.42% sus

Prognoză pe 12 luni

Medie 60.2 USD 30.42%

Maxim 75 USD

Minim 48 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruUroGen Pharma Ltd - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 5 analiști care au acordat evaluări ale acțiunilor UroGen Pharma Ltd - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre UroGen Pharma Ltd

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301 for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; strategic research collaboration agreement with MD Anderson focusing on the sequential use of UGN-201 and UGN-301 for the treatment of NMIBC; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 in low-grade intermediate risk NMIBC and UGN-104 in low-grade upper tract urothelial carcinoma. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.